Lv7
3720 积分 2025-05-24 加入
Evaluation of the specificity of trigeminal nerve enlargement in the diagnosis of IgG4-related ophthalmic disease
2个月前
已完结
Malignancies in Immunoglobulin G4-related ophthalmic disease
2个月前
已完结
Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study
2个月前
已完结
Infraorbital nerve involvement as a pathognomonic sign of IgG4-related ophthalmic disease
2个月前
已完结
Infraorbital nerve enlargement in a patient with IgG4-related disease
2个月前
已完结
Corneal endothelial evaluations in immunoglobulin g4‐related ophthalmic disease
2个月前
已完结
Malignancies in Immunoglobulin G4-related ophthalmic disease
2个月前
已完结
The immunological pathogenesis of IgG4-related disease categorized by clinical characteristics
2个月前
已完结
Time to improvement following teprotumumab treatment of thyroid eye disease: real world experience
7个月前
已完结
Effects of Teprotumumab and Role of Human Leukocyte Antigens Markers in Patients With Thyroid Eye Disease
7个月前
已完结
皖公网安备34019202002308
